U.S. ‘Smart Pill’ Industry Could Double, Top $1.2 Billion By 2021

May 25, 2017

Wellesley, Mass., May 25, 2017 – A new global market study by BCC Research indicates a growth trajectory above 20%-per-year in the ‘Smart Pill’ segment of the medical and pharmaceutical industry through 2021. These devices support patient monitoring, diagnostics and medicine delivery for a broad spectrum of companies.

Technologies and new uses worldwide could drive U.S. sales to reach USD $1.2 billion in annual sales by 2021 – more than twice 2016 sales levels. The industry is poised for CAGR above 20% — as much as 23% annual growth in Asia — during the next five years, according to BCC Research's Smart Pills: Applications and Global Markets.

In one example, the choice of ‘capsule endoscopy’ rather than a surgical option is creating new markets and options for doctors. Smart devices that can be swallowed are able to report on pH levels, temperature, pressure and other conditions from inside the throat, stomach and gastrointestinal tract.

Research Highlights

• U.S. sales of smart pill devices were 55% of the global total, or $468 million in 2016, and growing adoption in Europe and Asia also will drive the industry.
• Pharmaceutical companies, seeing growing generics competition are finding that devices that control drug release or report on patient condition can add new value to patients and doctors.
• These devices apply new options for more than 40 diseases of the intestines, stomach, bowel and other organs where monitoring is a challenge.

"Regulatory approval is a crucial factor but the conveniences and additional information coming from smart pill applications is already showing compelling arguments,” says Robert Hunter, BCC Research editor. "These are the body’s secrets that can now be treated with better, personalized data. This has implications for cancer care, nutrition, obesity treatments for both disease and chronic care conditions, improving things between patient and doctor – using information to replace anecdotes.”

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.

Smart Pills: Applications and Global Markets( PHM181A )
Publish Date: May 2017    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.